Log in

Relevant bibliographies by topics / Pharmaceutical development pharmaceutical industry / Journal articles

To see the other types of publications on this topic, follow the link: Pharmaceutical development pharmaceutical industry.

Journal articles on the topic 'Pharmaceutical development pharmaceutical industry'

Author: Grafiati

Published: 4 June 2025

Last updated: 1 August 2025

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the top 50 journal articles for your research on the topic 'Pharmaceutical development pharmaceutical industry.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.

1

DOLENINA, Ol'ga E., and Viktoriya D. PEREVALOVA. "Innovative processes in the German pharmaceutical industry." Economic Analysis: Theory and Practice 22, no. 7 (2023): 1384–96. http://dx.doi.org/10.24891/ea.22.7.1384.

Full text

Abstract:

Subject. The article addresses Germany's competitive position in the global pharmaceutical market and R&D development in the pharmaceutical industry. Objectives. The purpose is to provide a unique comprehensive study of innovative processes development in the pharmaceutical industry, using the case of German companies, explore innovative approaches to solving production problems, identify leading German companies in the field of biotechnology, and reveal the most promising areas for the development of German pharmaceuticals. Methods. We employ statistical and cartographic methods, and meth

APA, Harvard, Vancouver, ISO, and other styles

2

Rasuleva, Maprat Rafikovna, Nodira Maxkampulatovna Aliyeva, and Saida Iskandarovna Djurayeva. "PROSPECTS FOR THE INTRODUCTION OF INNOVATIVE TECHNOLOGIES IN THE DEVELOPMENT OF THE PHARMACEUTICAL INDUSTRY." EURASIAN JOURNAL OF ACADEMIC RESEARCH 1, no. 3 (2021): 387–92. https://doi.org/10.5281/zenodo.4974273.

Full text

Abstract:

The article discusses the prospects, development and problems of innovative technologies in the pharmaceutical industry. Information technology is the most important factor in the transformation of the pharmaceutical industry. Innovative technologies will be the key to this transformation. Innovation in the pharmaceutical̆ industry has a unique role to play. It is scientific discoveries and developments that are the driving force of development and the basis for its existence.

APA, Harvard, Vancouver, ISO, and other styles

3

Kopteva, Lyudmila, Artur Budagov, and Lyudmila Shabalina. "Russian pharmaceutical industry innovative development: present state and prospects." E3S Web of Conferences 284 (2021): 02017. http://dx.doi.org/10.1051/e3sconf/202128402017.

Full text

Abstract:

In the article the innovative development of the Russian Federation pharmaceutical industry is considered in the context of global trends and world pharmaceutical market development priority areas. The countries’ patent activity in the sphere of medical technologies and pharmaceuticals is considered. The main technological and conceptual trends in the development of the Russian pharmaceutical market have been identified. The results obtained are aimed at the Russian pharmaceutical market innovative development in the context of global instability. The practical significance of the study lies i

APA, Harvard, Vancouver, ISO, and other styles

4

Boychev, Vladimir. "TECHNOLOGICAL FUTURE OF PHARMACEUTICAL INDUSTRY– DEVELOPMENT PERSPECTIVES." Entrepreneurship 10, no. 1 (2022): 68–77. http://dx.doi.org/10.37708/ep.swu.v10i1.7.

Full text

Abstract:

Digital revolution and innovations are the modern phenomena pharmaceutical industry should take advantage of. The prevention of diseases will also facilitate the progress of the sector. This publication examines the key factors influencing pharmaceutical industry behavior and bears the potential to drastically change the sector in the upcoming years. The forthcoming challenges and changes appearing on the horizon require careful and precise consideration of new kinds of markets, alternative business models or even a complete change in the way pharmaceutical companies operate. The future of the

APA, Harvard, Vancouver, ISO, and other styles

5

Nasir, Fazli. "Welcome to Pharmaceutical Communications." Pharmaceutical Communications 1, no. 01 (2022): 01. http://dx.doi.org/10.55627/pharma.001.001.0203.

Full text

Abstract:

Welcome to the inaugural issue of Pharmaceutical Communications-a biannual, open access, and peer-reviewed journal aiming to publish high-quality research articles in the field of basic & advanced pharmaceutics and pharmaceutical technology. Pharmaceutical Communications is a biannual, peer-reviewed journal published online and in print that primarily publishes research articles and reviews that focus on basic and advanced pharmaceutics. The journal accepts manuscripts related to but not limited to, the processing of pharmaceuticals, such as crystallization, lyophilization, chemical stabil

APA, Harvard, Vancouver, ISO, and other styles

6

Nezhnikova, Ekaterina V., and Maksim V. Maksimchuk. "Pharmaceutical industry in Russia: problems and prospects of development." RUDN Journal of Economics 27, no. 1 (2019): 102–12. http://dx.doi.org/10.22363/2313-2329-2019-27-1-102-112.

Full text

Abstract:

The paper analyzes the changes in the Russian pharmaceutical market and discusses the prospects and trends of the Russian pharmaceutical industry. The purpose of the work is to identify the main directions and problems of development and functioning of the pharmaceutical industry of the Russian Federation. Over the past few years, the state has created a strategy for the development of pharmaceuticals, which can bring the industry to a new level. However, existing problems and the lack of an integrated approach hamper the fulfillment of this task. Based on the analysis, the author provides a l

APA, Harvard, Vancouver, ISO, and other styles

7

Deuskar, Vishwa. "Comparative Profitability Analysis: Sun Pharmaceutical Company & Cipla Pharmaceutical Company." RESEARCH REVIEW International Journal of Multidisciplinary 7, no. 8 (2022): 109–14. http://dx.doi.org/10.31305/rrijm.2022.v07.i08.017.

Full text

Abstract:

The Indian pharmaceutical industry is growing tremendously. Indian pharmaceutical industry plays a prominent role in the global pharmaceutical industry. It contributes to the welfare of people and provides significant socio-economic benefits to the society through creation of jobs, supply chains and community development. This study has been done for important evaluation of two Indian giant pharmaceutical industries i.e. Sun pharmaceutical Ltd. and Cipla pharmaceuticals. This study focuses on to analyze the profitability of the selected pharmaceutical companies of India and to do comparative s

APA, Harvard, Vancouver, ISO, and other styles

8

Mamedyarov, Z. A. "Pharmaceutical Industry Development in the Midst of Crisis: Global Trends." MIR (Modernization. Innovation. Research) 11, no. 4 (2020): 398–408. http://dx.doi.org/10.18184/2079-4665.2020.11.4.398-408.

Full text

Abstract:

Purpose: the main purpose of the article was to study the trends in the global pharmaceutical industry, as one of the most knowledge-intensive in the world economy, against the background of the 2020 COVID-related crisis. The task was to study the impact of the economic crisis on the priorities of the largest pharmaceutical multinationals, to link them with trends in the restructuring of health care systems, as well as to analyze and assess the potential impact of Brexit on the European pharma industry, starting from 2021.Methods: the work is based on a comparative analysis of trends in the re

APA, Harvard, Vancouver, ISO, and other styles

9

Doostzadeh, Ebrahim, Hussein Shabaninejad, Hesamoddin Madani, and Zahra Ahani Amineh. "A FRAMEWORK FOR EVALUATION OF PHARMACEUTICAL INDUSTRY DEVELOPMENT IN DEVELOPING COUNTRIES: EVIDENCE FROM IRAN." Asian Journal of Pharmaceutical and Clinical Research 9, no. 5 (2016): 50. http://dx.doi.org/10.22159/ajpcr.2016.v9i5.10099.

Full text

Abstract:

ABSTRACTObjectives: The pharmaceutical market is a complex market due to its complicated supply chain and the extent of government regulations in allaspects of the trade lifecycle of drug development. Considering the importance of pharmaceuticals for society and the relevant trend of globalization,managing pharmaceutical industry effectively and efficiently is vital, particularly in developing countries. The present study determines the factorsaffecting the development of the Iranian pharmaceutical industry based on pharmaceutical mangers’ point of view.Methods: In this study, we assessed mana

APA, Harvard, Vancouver, ISO, and other styles

10

Sinitsova, Yana Sergeevna. "ASSESSMENT OF INNOVATIVE ACTIVITY OF PHARMACEUTICAL TRANSNATIONAL CORPORATIONS IN THE WORLD PHARMACEUTICAL INDUSTRY." Scientific Review: Theory and Practice 12, no. 5 (2022): 778–86. http://dx.doi.org/10.35679/2226-0226-2022-12-5-778-786.

Full text

Abstract:

The article describes and applies the author's methodology for analyzing and evaluating the innovative activity of global pharmaceutical transnational corporations. The relevance of the analysis is determined by the extremely high social significance of the pharmaceutical industry for the world population, states of the world and pharmaceutical manufacturing companies. Due to the long development cycle of original, innovative medicines and the high cost of clinical trials, this category of products is produced by global transnational corporations that have large production facilities and resea

APA, Harvard, Vancouver, ISO, and other styles

11

Opriş, Mircea Constantin, Dana Corina Deselnicu, and Fowzi-Constantin Crasoveanu. "Romanian Market Strategies in the Pharmaceutical Industry." Proceedings of the International Conference on Business Excellence 17, no. 1 (2023): 1404–12. http://dx.doi.org/10.2478/picbe-2023-0126.

Full text

Abstract:

Abstract Understanding the actions taken by pharmaceutical companies to counter competition requires information on how the pharmaceutical sector is built. The pharmaceutical market, mentioned in this paper, contains all companies that produce or develop pharmaceuticals or compounds that are used to produce drugs and all other participants that interact with those companies for the purpose of selling or buying a drug. It is also necessary to understand market participants and the importance of an economy for maintaining this growing sector by supporting its production and development, in order

APA, Harvard, Vancouver, ISO, and other styles

12

Alajärvi, Lasse, Johanna Timonen, Piia Lavikainen, and Janne Martikainen. "Attitudes and Considerations towards Pharmaceuticals-Related Environmental Issues among Finnish Population." Sustainability 13, no. 22 (2021): 12930. http://dx.doi.org/10.3390/su132212930.

Full text

Abstract:

A number of policy recommendations identify the general public as a key participant in environmentally sustainable pharmaceutical policies. However, research into pharmaceuticals-related environmental issues from the population perspective is scarce. We studied the awareness among Finnish adults (n = 2030) of pharmaceutical residues in Finnish waterways, their perceived environmental sources, views on pharmaceuticals-related environmental issues, and their association with background characteristics. Of the respondents, 89.5% were aware of the presence of pharmaceuticals in Finnish waterways.

APA, Harvard, Vancouver, ISO, and other styles

13

Salikhova, Olena, and Daria Honcharenko. "Policy of endogenous development of pharmaceuticals in China: lessons for Ukraine." Economy and forecasting 2020, no. 2 (2020): 105–19. http://dx.doi.org/10.15407/econforecast2020.02.105.

Full text

Abstract:

This article provides overview of the programs and plans, tools of scientific and technological, innovation and industry policies for new drug discovery. The authors substantiate that China has a government-led integrated approach to protecting and strengthening pharmaceutical sector. Discovered and proved the fact that the Chinese Government is encouraging R&D in the pharmaceutical sector, with special attention to the biotechnologies and is providing substantial support in the form of subsidies, tax incentives and establishment of special high-tech zones to encourage the production of ne

APA, Harvard, Vancouver, ISO, and other styles

14

Ivanova, S. V., M. A. Erganzhiev, and S. V. Murashova. "The Role of Intellectual Property in the Innovation Activities of Russian Pharmaceutical Companies." Economics. Law. Innovaion, no. 4 (December 29, 2022): 38–47. http://dx.doi.org/10.17586/2713-1874-2022-4-38-47.

Full text

Abstract:

The authors of the study analyze the role played by the intellectual property of domestic and foreign applicants in the Russian segment of the international pharmaceutical market, based on data on patent activity. Modern realities of the Russian pharmaceutical industry are formed under the influence of two multidirectional processes – protectionist policy and technology development in the format of open innovations, which influence the choice of tools for solving the problems of innovation management. Domestic patent holders began to take an increasingly tough stance against competitors from f

APA, Harvard, Vancouver, ISO, and other styles

15

Salikhova, Olena, and Daria Honcharenko. "Ukraine's pharmaceuticals: from dependence to endogenous development." Ekonomìka ì prognozuvannâ 2020, no. 4 (2020): 7–35. http://dx.doi.org/10.15407/eip2020.04.007.

Full text

Abstract:

The article substantiates various theoretical and applied principles of developing high-tech pharmaceutical industries (HTPI). It is established that the key problem of developing countries in this area is the dependence on resources and markets of developed countries, while the involvement of advanced foreign technologies can be a catalyst for increasing the technological potential of host countries (subject to the availability of proper knowledge and human capital, changes in the institutional environment, and improved the framework conditions for innovation). In the context of the developme

APA, Harvard, Vancouver, ISO, and other styles

16

Salikhova, Olena, and Daria Honcharenko. "Ukraine's pharmaceuticals: from dependence to endogenous development." Economy and forecasting 2020, no. 4 (2020): 5–33. http://dx.doi.org/10.15407/econforecast2020.04.005.

Full text

Abstract:

The article substantiates various theoretical and applied principles of developing high-tech pharmaceutical industries (HTPI). It is established that the key problem of developing countries in this area is the dependence on resources and markets of developed countries, while the involvement of advanced foreign technologies can be a catalyst for increasing the technological potential of host countries (subject to the availability of proper knowledge and human capital, changes in the institutional environment, and improved the framework conditions for innovation). In the context of the developme

APA, Harvard, Vancouver, ISO, and other styles

17

SUPREET, KAMBOJ, and CHOPRA SHRUTI. "QUALITY BY DESIGN (QBD) IN PHARMACEUTICAL INDUSTRY." International Journal of Current Pharmaceutical Review and Research 6, no. 2 (2015): 142–48. https://doi.org/10.5281/zenodo.12687671.

Full text

Abstract:

In 2004 US Food and Drug Administration (FDA), as part of the Process Analytical Technology Guidance,introduced the idea of Quality by Design (QbD). The core objective was to design quality into the process andproduct rather than try to check quality of the product at the end of production. It has been known since long timethat “quality by testing” is a low-yield and costly strategy. ICH, in 2005, outlined the concept of design space in itsQ8 guideline related to development of pharmaceuticals. Since that time, pharmaceutical companies, despitedepending on innovation for their live

APA, Harvard, Vancouver, ISO, and other styles

18

Madalaimuthu, Malvika Mishra. "Regulatory in the Pharmaceutical Industry." Journal of Social Science and Humanities 7, no. 3 (2025): 37–42. https://doi.org/10.53469/jssh.2025.7(03).08.

Full text

Abstract:

Regulatory Affairs (RA) is a crucial profession in pharmaceuticals, medical devices, and biotechnological industries, encompassing scientific and legal aspects of drug development. It helps companies avoid issues and ensures commercialization. RA faces challenges like geopolitical shifts, green economy, and COVID-19, impacting new therapies and their role.[1] Drug Regulatory Affairs (DRA) is a crucial unit in pharmaceutical companies, providing strategic, tactical, and operational support to expedite the development and delivery of safety and efficacy in pharmaceuticals, veterinary medicines,

APA, Harvard, Vancouver, ISO, and other styles

19

Billi Noaman, Samar, and Haissam Lakkis. "Lebanese Pharmaceuticals and Healthcare Industry: Investing in the Pharmaceutical Industry to Promote Exports." Lebanese Science Journal 23, no. 2 (2022): 178–90. http://dx.doi.org/10.22453/lsj-023.2.178-190.

Full text

Abstract:

Compared to importation, the pharmaceutical production in Lebanon is still weak. The generics prescription is neglected according to the medicines of origin as only big brands dominate the Lebanese market. Despite the agreements between Lebanon and other Arab countries, the nature of the regulatory environment in the latter is likely to be a substantial obstacle that prevents the access of the Lebanese medicines to the markets of the Arab countries. On the other hand, the development of a new market access remains a necessity for increasing the volume of pharmaceutical exports. This paper aims

APA, Harvard, Vancouver, ISO, and other styles

20

Naimat, Nasihah, Mimi Sofiah Ahmad Mustafa, Nasreen Miza Hilmy Nasrijal, and Ida Rahayu Mahat. "Challenges and Opportunities in the Halal Pharmaceutical Industry in Malaysia." Information Management and Business Review 15, no. 4(I) (2024): 73–78. http://dx.doi.org/10.22610/imbr.v15i4(i).3565.

Full text

Abstract:

Following the global significance of halal pharmaceutical products, Malaysia has positioned itself as a key manufacturer to increase industrial demand. This study examines Malaysia's halal pharmaceutical industry by internalizing consumer preferences for halal pharmaceuticals and the associated complexities. The data derived from literature reviews were subjected to documentation analysis. Consumer preference was substantially influenced by religious beliefs, product quality, and health concerns. Halal certification, cross-contamination concerns, and regulatory compliance were the key issues u

APA, Harvard, Vancouver, ISO, and other styles

21

Rajshree, Sharma, Vaibhav Akarsh, Singh Rohan, and SteffanPanicker. "Pharmaceutical Sector Digitalization." International Journal of Innovative Science and Research Technology 7, no. 7 (2022): 1267–72. https://doi.org/10.5281/zenodo.6997006.

Full text

Abstract:

In today's climate, "digital" is become an essential part of almost everything. All sectors would move more quickly into the digital era. The pharmaceutical industry has not yet fully adopted online marketing, with the exception of the webpage. Currently, the country is facing several difficulties. In terms of marketing, the pharmaceutical sector dominates all other sectors. This generation is producing more medications.Through social media platforms and e-commerce websites, businesses are marketing themselves online. Customers can so make online purchases. While some businesses

APA, Harvard, Vancouver, ISO, and other styles

22

Mamedyarov, Z. A. "Strategic Role of the Pharmaceutical Industry in the Сontext of the Global Pandemic". Journal of International Analytics 11, № 4 (2021): 122–36. http://dx.doi.org/10.46272/2587-8476-2020-11-4-122-136.

Full text

Abstract:

The strategic importance of the pharmaceutical industry for the scientific, technological and economic development of countries determines its impact on international processes. The paper traces the current trends in the growth of innovative competition in pharmaceuticals and biotechnology, taking into account the factor of the COVID-19 pandemic. The following areas of increased competition are highlighted: diversification of supply of active pharmaceutical substances, regulators’ permission of the newest drugs to access the market, competition of pharmaceutical companies for capital and compe

APA, Harvard, Vancouver, ISO, and other styles

23

Monali, Bora* Vishal Rasve Poonam Ghorpade Mahesh Kshirsagar Kalpesh Tated. "Quality by design in pharmaceutical industries: a review." International Journal of Advances in Pharmacy Medicine and Bioallied Sciences 10, no. 3 (2022): 108–16. https://doi.org/10.5281/zenodo.7708999.

Full text

Abstract:

Quality by design (Qbd) is a modern approach to the quality of pharmaceuticals. It is describing the use of Qbd to ensure the quality of pharmaceuticals. In this review, Qbd is described as some elements. It is based on ICH Guidelines Q8 for pharmaceutical development, Q9 for quality risk management, Q10 for pharmaceutical quality systems. It also gives definitions, and applications, in Qbd in the pharmaceutical industry development and manufacturing of pharmaceutical products. Quality by design is a treading concept that is widely utilized for the optimization and development of pharmaceutica

APA, Harvard, Vancouver, ISO, and other styles

24

Mane, Sanvidha A., Ravindra L. Bakal, and Pooja R. Hatwar. "Artificial Intelligence in Pharmaceutical Research." Journal of Drug Delivery and Therapeutics 15, no. 6 (2025): 260–67. https://doi.org/10.22270/jddt.v15i6.7234.

Full text

Abstract:

Artificial intelligence (AI) is transforming the pharmaceutical industry by accelerating medication development and discovery. AI technologies, including machine learning and deep learning, are being applied in various areas, such as drug design, target discovery, preclinical research, and personalized medicine. AI can analyze vast amounts of data, identify patterns, and make predictions, thereby improving the efficiency and effectiveness of the drug development process. This review highlights the applications of AI in pharmaceutical research, including drug discovery, target identification, a

APA, Harvard, Vancouver, ISO, and other styles

25

Honcharenko, Daria. "PHARMACEUTICAL INDUSTRY DEVELOPMENT: KEY POLICY INSTRUMENTS IN CHINA." EUREKA: Social and Humanities 4 (July 31, 2020): 3–9. http://dx.doi.org/10.21303/2504-5571.2020.001369.

Full text

Abstract:

The article provides an overview of programs, plans, tools of scientific and technological, innovation and industrial policy aimed at creating and producing new drugs in China; it is substantiated that the Chinese government uses an integrated approach in the implementation of mechanisms to protect and strengthen the pharmaceutical industry. It is demonstrated that the Chinese government provides business support in the form of subsidies, tax incentives, the creation of special zones for the development of high-tech industries, and helps to attract foreign direct investment in contract manufac

APA, Harvard, Vancouver, ISO, and other styles

26

Daria, Honcharenko. "PHARMACEUTICAL INDUSTRY DEVELOPMENT: KEY POLICY INSTRUMENTS IN CHINA." EUREKA: Social and Humanities, no. 4 (July 31, 2020): 3–9. https://doi.org/10.21303/2504-5571.2020.001369.

Full text

Abstract:

The article provides an overview of programs, plans, tools of scientific and technological, innovation and industrial policy aimed at creating and producing new drugs in China; it is substantiated that the Chinese government uses an integrated approach in the implementation of mechanisms to protect and strengthen the pharmaceutical industry. It is demonstrated that the Chinese government provides business support in the form of subsidies, tax incentives, the creation of special zones for the development of high-tech industries, and helps to attract foreign direct investment in contract manufac

APA, Harvard, Vancouver, ISO, and other styles

27

Максимчук, М. В., and А. В. Кореневская. "PROSPECTS FOR THE USE OF HYDROCARBON RESOURCES IN THE PHARMACEUTICAL INDUSTRY." Scientific Journal ECONOMIC SYSTEMS 1, no. 210 (2022): 163–72. http://dx.doi.org/10.29030/2309-2076-2022-15-2-163-172.

Full text

Abstract:

The article examines the main methods of processing hydrocarbon resources in the pharmaceutical industry. Analyzed are the main factors constraining the use of raw materials obtained from the processing of hydrocarbon resources in the pharmaceutical industry. The paper deals with the problems of using petroleum products in the context of the pharmaceutical industry. The author examines the state strategy for the development of pharmaceuticals, which is able to bring the industry to a new level. However, existing problems and the lack of an integrated approach hinder the implementation of this

APA, Harvard, Vancouver, ISO, and other styles

28

Venkataramana Gadi, Jyothsna M, Nookaratnam Pirla, and Bhavani B. "A Comprehensive Review of 3D Printing Applications in Drug Development and Delivery." Journal of Pharma Insights and Research 2, no. 4 (2024): 139–45. http://dx.doi.org/10.69613/5tp1qg79.

Full text

Abstract:

Three-dimensional (3D) printing has emerged as a transformative technology in the pharmaceutical industry, offering unprecedented opportunities for personalized medicine and advanced drug delivery systems. This review explores the diverse applications of 3D printing in drug development and delivery, highlighting its potential to revolutionize pharmaceutical manufacturing. The primary 3D printing technologies employed in this field include fused deposition modeling (FDM), stereolithography (SLA), and powder bed fusion (PBF), each with unique strengths suited for different aspects of drug produc

APA, Harvard, Vancouver, ISO, and other styles

29

CONTRACTOR, SUNIL H., PIYUSH KUMAR, and THOMAS W. LEIGH. "THE IMPACT OF GOVERNANCE MECHANISMS ON ESCALATION OF COMMITMENT." International Journal of Innovation Management 16, no. 04 (2012): 1250023. http://dx.doi.org/10.1142/s1363919612500235.

Full text

Abstract:

There are conflicting opinions on whether the existing US legal and economic environment for pharmaceutical research is conducive for the repurposing of patent-protected drugs. This article therefore addresses the following innovation policy questions: Does US patent law and regulatory policy assign sufficient value to new use patents in the pharmaceutical industry? If present law and regulatory policy does assign sufficient value, what evidence is there that the pharmaceutical industry is actively involved in technology strategies to repurpose existing pharmaceuticals? Based on an evaluation

APA, Harvard, Vancouver, ISO, and other styles

30

Aliyeva, N. A., A. S. Manap, and M. M. Issabayev. "Kazakhstan’s pharmaceutical market in the context of global trends." ECONOMIC Series of the Bulletin of the L N Gumilyov ENU, no. 4 (February 2, 2023): 21–35. http://dx.doi.org/10.32523/2079-620x-2020-4-21-35.

Full text

Abstract:

Pharmaceuticals industry is among of social importance and prospective lines fordevelopment of scientific research especially due to coronavirus pandemic, which showed theimportance of the level of healthcare development.The provided literature review based on previous studies on the analysis of the pharmaceuticalmarket, marketing research, review and statistical data. Were used following general scientificmethods: method of scientific analysis, statistical and comparative analysis, inductive anddeductive methods.The dynamics of global pharmaceutical market development was studied, determined

APA, Harvard, Vancouver, ISO, and other styles

31

DOLENINA, Ol'ga E., and Viktoriya D. PEREVALOVA. "German companies in the global pharmaceutical market." Financial Analytics: Science and Experience 16, no. 3 (2023): 266–84. http://dx.doi.org/10.24891/fa.16.3.266.

Full text

Abstract:

Subject. The article addresses the competitive advantages of Germany in the global pharmaceutical market and the growth of performance of its pharmaceutical companies due to the high incidence rate in the world; the specialization of companies and the geography of German pharmaceutical products. Objectives. The aim is to perform a comprehensive study of activities of German pharmaceutical companies, their competitiveness in the world market, specialization of production, and development prospects. Methods. The study employs statistical and cartographic methods, as well as methods of comparativ

APA, Harvard, Vancouver, ISO, and other styles

32

Olena, SALIKHOVA, and HONCHARENKO Daria. "HIGH-TECH PHARMACEUTICAL MANUFACTURING IN UKRAINE: CHALLENGES OF EUROPEAN INTEGRATION." Foreign trade: economics, finance, law 118, no. 5 (2021): 128–54. http://dx.doi.org/10.31617/zt.knute.2021(118)08.

Full text

Abstract:

Background. The crisis COVID-19 pandemic has highlighted that EU have strategic dependencies, particularly in the most sensitive industrial ecosystems such as for health. Ukraine implements the policy of European economic integration and the development of the pharmaceutical sector must take into account both European considerations and national interests. Analysis of recent researches and publications revealed that the crisis COVID-19 pandemic revealed pharmaceutical industry problems; that require further study for adequate reproduction of the best practices in Ukraine. The aim of the articl

APA, Harvard, Vancouver, ISO, and other styles

33

Adulapuram Aroon, Akuthota Kavya, Mudhadapu Swetha rani, Mandapati Harshitha, and Nagula Anannya. "Evolution of quality assurance in pharmaceutical industry." World Journal of Biology Pharmacy and Health Sciences 20, no. 2 (2024): 656–61. http://dx.doi.org/10.30574/wjbphs.2024.20.2.0937.

Full text

Abstract:

It is brief review of History of Quality control, Timeline of evolution of quality assurance in pharmacy field, GMP guidelines and current trends. Quality assurance is a term used in systematic process of determining whether a product or service meets specified requirements. Quality assurance also involves establishing and maintaining quality management systems to continually improve processes and prevent defects or deviations. Overall, a Quality assurance plays a critical role in safeguarding public health and maintaining the integrity. The main functions are to provide consumer satisfaction.

APA, Harvard, Vancouver, ISO, and other styles

34

Iyengar, Renganthan. "PHARMACEUTICAL PRICING POLICY AND CONTROL– INDIAN PERSPECTIVE." Asian Journal of Pharmaceutical and Clinical Research 9, no. 6 (2016): 305. http://dx.doi.org/10.22159/ajpcr.2016.v9i6.14461.

Full text

Abstract:

ABSTRACTPharmaceutical sector is playing a vital role towards the wellness of the people and economic development of India. The innovation, development, production and marketing of medicines are accountable to pharmaceutical industry. Drugs and pharmaceuticals, healthcare delivery, medical devices among others come under the purview of healthcare sector. It is the duty of the Government to ensure the availability of the lifesaving drugs at reasonable prices by means of considering the interest of both the producers and the buyers. In order to safeguard the public health, National Pharmaceutica

APA, Harvard, Vancouver, ISO, and other styles

35

Monaghan, Maura J., and Michael S. Monaghan. "Do Market Components Account for Higher US Prescription Prices?" Annals of Pharmacotherapy 30, no. 12 (1996): 1489–94. http://dx.doi.org/10.1177/106002809603001219.

Full text

Abstract:

BACKGROUND: Although only 7–8% of US healthcare expenditures are spent on prescription drug products, the pharmaceutical industry's profitability and high cost of prescriptions to consumers make prescription drugs a visible target for reform. When compared with other products, it appears as if unfair pricing tactics are used. The pharmaceutical industry cites costs of research and development and a short patent life as justifiable grounds for high prices, but the reason why US drug prices appear to be so high has yet to be answered. OBJECTIVE: To examine identified components of the pharmaceut

APA, Harvard, Vancouver, ISO, and other styles

36

Nagy, Szabolcs, and R. R. Asmyatullin. "The pharmaceutical industry of the world: investment in R & D in the postcovid period." International Trade and Trade Policy 8, no. 4 (2023): 62–70. http://dx.doi.org/10.21686/2410-7395-2022-3-62-70.

Full text

Abstract:

In the article, the authors analyzed the activities of pharmaceutical companies in the world in the field of research and development (R & D) on the basis of international and Russian statistics. The financing of R & D in pharmaceuticals traditionally retains its decisive role in the development of both the industry as a whole and the global economy and the social sphere in the conditions of the outpacing growth of the age qualification of the world's population, which is the relevance of the article. The purpose of the article is to identify new trends in the development of investment

APA, Harvard, Vancouver, ISO, and other styles

37

Movsesyan, Areg. "Prospects for the development of Ukraine’s pharmaceutical market in the wartime and post-war economy." Scientific notes, no. 37 (December 21, 2024): 55–62. https://doi.org/10.33111/vz_kneu.37.24.04.05.033.039.

Full text

Abstract:

The pharmaceutical market of Ukraine has undergone significant changes and challenges due to the ongoing war and associated economic difficulties. Military actions have resulted in substantial damage and destruction of production and logistics facilities, disruptions in the supply of medicines, reduced availability of pharmaceuticals for the population, and challenges in importing raw materials and finished drugs. On the other hand, this crisis situation has revealed new opportunities for the development of domestic production and localization of pharmaceutical products. This could strengthen

APA, Harvard, Vancouver, ISO, and other styles

38

Y, Ndao, and Diarra M. "Development of Pharmaceutical Industry in Senegal." American Journal of Pharmacy And Health Research 6, no. 1 (2018): 21–30. http://dx.doi.org/10.46624/ajphr.2018.v6.i1.003.

Full text

APA, Harvard, Vancouver, ISO, and other styles

39

Deshkar, Anuradha T., Ujwala P. Gawali, and Prashant A. Shirure. "Environmental pharmacology: an emerging science." International Journal of Basic & Clinical Pharmacology 7, no. 3 (2018): 359. http://dx.doi.org/10.18203/2319-2003.ijbcp20180645.

Full text

Abstract:

With continuous rapid expansion of the human population there is escalating demand for resources, including human and veterinary pharmaceuticals. This has lead to rapid development of global pharmaceutical industry and with that increase in issues caused by pharmaceutical products. In recent years a great concern has been expressed over the occurrence and persistence of pharmaceutical products in the environment and their potential impact on environment. Owing to this the new branch of science called environmental pharmacology has sprouted. Environmental pharmacology deals with dispersion and

APA, Harvard, Vancouver, ISO, and other styles

40

Antonopoulou, Maria. "Homogeneous and Heterogeneous Photocatalysis for the Treatment of Pharmaceutical Industry Wastewaters: A Review." Toxics 10, no. 9 (2022): 539. http://dx.doi.org/10.3390/toxics10090539.

Full text

Abstract:

Pharmaceuticals are biologically active compounds used for therapeutical purposes in humans and animals. Pharmaceuticals enter water bodies in various ways and are detected at concentrations of ng L−1–μg L−1. Their presence in the environment, and especially long-term pollution, can cause toxic effects on the aquatic ecosystems. The pharmaceutical industry is one of the main sources introducing these compounds in aquatic systems through the disposal of untreated or partially treated wastewaters produced during the different procedures in the manufacturing process. Pharmaceutical industry waste

APA, Harvard, Vancouver, ISO, and other styles

41

Mei, Yan Lan, and Ping Gui. "Study on Bio-Pharmaceutical Industry Development Route and Strategy." Applied Mechanics and Materials 365-366 (August 2013): 1350–54. http://dx.doi.org/10.4028/www.scientific.net/amm.365-366.1350.

Full text

Abstract:

Since recent twenty years, the rapid development of biotechnology has boosted the rapid development of bio-pharmaceutical industry,and bio-pharmaceutical has already stepped into our daily life.Starting from the summary of bio-pharmaceutical industry,the paper makes a SWOT analysis on bio-pharmaceutical industry,making the strengths,weaknesses,opportunities and threats of bio-pharmaceutical industry clear;and focusing on a deep study on the development routes and all stages strategies of bio-pharmaceutical industry in our country.

APA, Harvard, Vancouver, ISO, and other styles

42

Terenteva, Natalya, and Julia Matyush. "INNOVATIVE MARKETING AS A CONDITION FOR THE DEVELOPMENT OF PHARMACEUTICAL INDUSTRY ENTERPRISES IN THE CONTEXT OF DIGITALIZATION." Actual Problems of Economics 1, no. 267 (2023): 49–56. http://dx.doi.org/10.32752/1993-6788-2023-1-267-49-56.

Full text

Abstract:

Developing innovative potential in pharmaceuticals requires a comprehensive approach that includes investment in education and research, development of risk management strategies, and effective interaction with regulatory authorities. The article reveals the key principles on which pharmaceutical marketing is based and which take into account the specifics of the industry. These principles help pharmaceutical companies develop effective marketing strategies that contribute to their growth and success in a competitive environment. It has been established that the innovative potential of the pha

APA, Harvard, Vancouver, ISO, and other styles

43

Zhou, Lilong, Chen Ma, Jonathan Horlyck, Runjing Liu, and Jimmy Yun. "Development of Pharmaceutical VOCs Elimination by Catalytic Processes in China." Catalysts 10, no. 6 (2020): 668. http://dx.doi.org/10.3390/catal10060668.

Full text

Abstract:

As a byproduct of emerging as one of the world’s key producers of pharmaceuticals, China is now challenged by the emission of harmful pharmaceutical VOCs. In this review, the catalogue and volume of VOCs emitted by the pharmaceutical industry in China was introduced. The commonly used VOC removal processes and technologies was recommended by some typical examples. The progress of catalytic combustion, photocatalytic oxidation, non-thermal plasma, and electron beam treatment were presented, especially the development of catalysts. The advantages and shortages of these technologies in recent yea

APA, Harvard, Vancouver, ISO, and other styles

44

Gaurav, Abhishek. "Intellectual Property Right (IPR) And Patent in Pharmaceuticals Industry in India." INTERNATIONAL JOURNAL OF SCIENTIFIC RESEARCH IN ENGINEERING AND MANAGEMENT 09, no. 04 (2025): 1–9. https://doi.org/10.55041/ijsrem45176.

Full text

Abstract:

Patent is granting property right by the authority to the inventor. This grant provides the inventors exclusively right to the patent process. Design or inventions for a particular period especially in the pharmaceutical industry. Government agencies typically handle and approve the patent. In the United States the US patent and trademark office, which is the part of the department of commerce, handles the applications and grants the approval. Similarly in India the patents are controlled by the registrar of the patent department under the control of the central government. The pharmaceutical

APA, Harvard, Vancouver, ISO, and other styles

45

Jovanovic, Slobodanka. "Patents in the pharmaceutical industry." Chemical Industry 57, no. 3 (2003): 133–37. http://dx.doi.org/10.2298/hemind0303133j.

Full text

Abstract:

The pharmaceutical industry is characterized by dynamic development, the existence of big multinational companies and a global market. Such development of the pharmaceutical industry was highly influenced by the introduction of patent protection and compliance with intellectual property regulations. One of the most important international obligations is the TRIPS Agreement.

APA, Harvard, Vancouver, ISO, and other styles

46

Potseluyeva, L. A. "Higher pharmaceutical education in the Republic of Tatarstan: sources of formation of educational basis, it’s development, improvement, results and achievements." Kazan medical journal 93, no. 5 (2012): 705–11. http://dx.doi.org/10.17816/kmj1692.

Full text

Abstract:

The analysis of historical and bibliographic data of pharmaceutical education foundation in the Republic of Tatarstan is presented. Over than 200-year history of higher education in Kazan, started in 1804, determined the development of not only medical, but also pharmaceutical sciences. In Kazan Emperor’s University 4 faculties were founded, including the Faculty of Medical Sciences, that included the combined Department of chemistry, technology and pharmacy (pharmaceutics), which actually consisted of several departments. The Pharmaceutical Faculty was established in Kazan Medical Institute i

APA, Harvard, Vancouver, ISO, and other styles

47

Yang, Xinyi, and Fenxiao Chen. "Advances in Neural Networks for Pharmaceutical Applications." Asian Journal of Advanced Research and Reports 18, no. 1 (2024): 20–29. http://dx.doi.org/10.9734/ajarr/2024/v18i1595.

Full text

Abstract:

Artificial neural networks (ANNs) are rapidly changing the landscape of the pharmaceutical industry. Their unique capabilities, including collective computing, adaptive learning, and fault tolerance, make them ideal for tackling complex challenges in drug discovery, analysis, and personalized medicine. This article summarizes the latest research progress in ANNs for pharmacy, highlighting breakthroughs in areas like QSAR modeling for drug design, pharmacokinetic prediction, and optimization of pharmaceutical preparations. With their immense potential to accelerate drug development, improve dru

APA, Harvard, Vancouver, ISO, and other styles

48

Qi, Lin, and Xinrong Zeng. "Financial Performance Analysis under the Light Asset Operation Model of Tai Long Pharmaceutical Company." Frontiers in Business, Economics and Management 17, no. 1 (2024): 200–207. http://dx.doi.org/10.54097/5jfzy084.

Full text

Abstract:

With the rapid development of the pharmaceutical industry and the increasingly fierce competition, the light asset operation model has become a key strategic choice for transforming pharmaceutical companies. This paper takes Tai Long Pharmaceutical as a case study to analyze its CXO light asset operation model and financial characteristics in depth. By employing factor analysis, a comprehensive assessment of its economic performance is conducted, and suggestions aimed at enhancing Tai Long Pharmaceutical's financial performance are proposed based on the analysis results, to help the company ma

APA, Harvard, Vancouver, ISO, and other styles

49

Khairnar, Tejaswini* Kapde Shruti Kawale Sakshi Karad Rutika Aher Pankaj. "AI In Pharmaceutics: Current Application and Future Direction." International Journal of Pharmaceutical Sciences 3, no. 2 (2025): 586–99. https://doi.org/10.5281/zenodo.14836604.

Full text

Abstract:

The Pharmaceutical industry is undergoing a significant transformation with the integration of Artificial Intelligence (AI). AI is being applied across various stages of drug development, from discovery to clinical trials, to improved efficacy, accuracy, and patient outcome. Machine learning algorithms can analyse vast amount of data to identify potential drug targets, predict efficacy and safety, and streamline clinical trails management.AI-powered tool are also being used to developed personalised medicine approaches, tailoring treatment to individual patients based on their genetic profile,

APA, Harvard, Vancouver, ISO, and other styles

50

Evens, Ronald P. "The Biotechnology Industry." Journal of Pharmacy Practice 11, no. 1 (1998): 13–18. http://dx.doi.org/10.1177/089719009801100104.

Full text

Abstract:

Growth and change are the hallmarks of the developing biotechnology industry. Since the first approval of a biological product in 1982, over 40 biologicals, many of them medical breakthroughs, have been brought to market. The majority of biotechnology companies focus on developing human therapeutic agents, but about 25 percent of biotechnology companies focus on the diagnostic area, using monoclonal antibody technology, polymerase chain reaction (PCR) technology, and genetics to provide advances in diagnosis and disease monitoring. Structurally, few biotechnology firms are fully integrated com

APA, Harvard, Vancouver, ISO, and other styles

We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!